Impact of the Cardioplegia Interval on Myocardial Protection Using the Modified St. Thomas Solution in Minimally Invasive Mitral Valve Surgery: A Double-Center Study.

Nagashima, Kohei; Inoue, Takafumi; Nakanaga, Hiroshi; Matsuyama, Shigefumi; Geshi, Eiichi; Tabata, Minoru

Nagashima, Kohei; Inoue, Takafumi; Nakanaga, Hiroshi; Matsuyama, Shigefumi; Geshi, Eiichi; Tabata, Minoru.

Afiliação

Nagashima K; Department of Clinical Engineering, Toranomon Hospital, Tokyo, Japan.
Inoue T; Showa University Postgraduate School of Health Sciences, Tokyo, Japan.
Nakanaga H; Department of Cardiovascular Surgery, Toranomon Hospital, Tokyo, Japan; and.
Matsuyama S; Department of Cardiovascular Surgery, Toranomon Hospital, Tokyo, Japan; and.
Geshi E; Department of Cardiovascular Surgery, Toranomon Hospital, Tokyo, Japan; and.
Tabata M; Showa University Postgraduate School of Health Sciences, Tokyo, Japan.

J Extra Corpor Technol ; 54(2): 135-141, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35928335

Assuntos

Soluções Cardioplégicas; Valva Mitral; Soluções Cardioplégicas/uso terapêutico; Creatina Quinase Forma MB; Parada Cardíaca Induzida/métodos; Humanos; Valva Mitral/cirurgia; Cloreto de Potássio

Palavras-chave

cardioplegia; cardiopulmonary bypass; mitral valve surgery; modified St. Thomas solution.; myocardial protection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Soluções Cardioplégicas / Valva Mitral Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google